
San Ming R. Hui
Examiner (ID: 1844, Phone: (571)272-0626 , Office: P/1621 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1629, 1617, 1621, 1627, 1628 |
| Total Applications | 2265 |
| Issued Applications | 1024 |
| Pending Applications | 278 |
| Abandoned Applications | 986 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19096294
[patent_doc_number] => 20240115521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/470317
[patent_app_country] => US
[patent_app_date] => 2023-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18470317
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/470317 | COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL DISEASES | Sep 18, 2023 | Pending |
Array
(
[id] => 18893700
[patent_doc_number] => 20240009185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/467705
[patent_app_country] => US
[patent_app_date] => 2023-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18467705
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/467705 | COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS | Sep 13, 2023 | Abandoned |
Array
(
[id] => 19279107
[patent_doc_number] => 20240215578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => POLYSUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES, PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/368514
[patent_app_country] => US
[patent_app_date] => 2023-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6545
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18368514
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/368514 | POLYSUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES, PREPARATION METHOD AND USE THEREOF | Sep 13, 2023 | Pending |
Array
(
[id] => 19316690
[patent_doc_number] => 20240238230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/463873
[patent_app_country] => US
[patent_app_date] => 2023-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18463873
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/463873 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | Sep 7, 2023 | Pending |
Array
(
[id] => 18860184
[patent_doc_number] => 20230414618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => Methods of Administering Elagolix
[patent_app_type] => utility
[patent_app_number] => 18/462054
[patent_app_country] => US
[patent_app_date] => 2023-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18462054
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/462054 | Methods of Administering Elagolix | Sep 5, 2023 | Abandoned |
Array
(
[id] => 18860161
[patent_doc_number] => 20230414595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => EMULSIONS FOR LOCAL ANESTHETICS
[patent_app_type] => utility
[patent_app_number] => 18/462162
[patent_app_country] => US
[patent_app_date] => 2023-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18462162
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/462162 | EMULSIONS FOR LOCAL ANESTHETICS | Sep 5, 2023 | Pending |
Array
(
[id] => 18901315
[patent_doc_number] => 20240016800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => METHODS OF TREATING NEUROFIBROMATOSIS WITH PERILLYL ALCOHOL
[patent_app_type] => utility
[patent_app_number] => 18/461562
[patent_app_country] => US
[patent_app_date] => 2023-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18461562
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/461562 | METHODS OF TREATING NEUROFIBROMATOSIS WITH PERILLYL ALCOHOL | Sep 5, 2023 | Pending |
Array
(
[id] => 20802673
[patent_doc_number] => 12667561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-30
[patent_title] => Gel containing pirfenidone
[patent_app_type] => utility
[patent_app_number] => 18/458390
[patent_app_country] => US
[patent_app_date] => 2023-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18458390
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/458390 | Gel containing pirfenidone | Aug 29, 2023 | Issued |
Array
(
[id] => 18815879
[patent_doc_number] => 20230390218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => EPINEPHRINE SPRAY FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/453360
[patent_app_country] => US
[patent_app_date] => 2023-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19306
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18453360
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/453360 | EPINEPHRINE SPRAY FORMULATIONS | Aug 21, 2023 | Pending |
Array
(
[id] => 19170862
[patent_doc_number] => 20240156836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => METHODS OF TREATING TESTOSTERONE DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 18/451557
[patent_app_country] => US
[patent_app_date] => 2023-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18451557
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/451557 | METHODS OF TREATING TESTOSTERONE DEFICIENCY | Aug 16, 2023 | Pending |
Array
(
[id] => 18986369
[patent_doc_number] => 20240058338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => COMBINATION OF RAF INHIBITOR AND MEK INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 18/450638
[patent_app_country] => US
[patent_app_date] => 2023-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18450638
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/450638 | COMBINATION OF RAF INHIBITOR AND MEK INHIBITOR | Aug 15, 2023 | Pending |
| 18/234232 | METHODS AND COMPOSITIONS FOR REDUCING SYMPTOMS OF PARKINSON'S DISEASE | Aug 14, 2023 | Abandoned |
Array
(
[id] => 18815949
[patent_doc_number] => 20230390288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => SOLID DOSE PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/447892
[patent_app_country] => US
[patent_app_date] => 2023-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -77
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18447892
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/447892 | SOLID DOSE PHARMACEUTICAL COMPOSITION | Aug 9, 2023 | Abandoned |
Array
(
[id] => 19768333
[patent_doc_number] => 20250049759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => PHARMACEUTICAL PREPARATION FOR ASSISTING IN PROMOTING SLEEP AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/230749
[patent_app_country] => US
[patent_app_date] => 2023-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18230749
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/230749 | PHARMACEUTICAL PREPARATION FOR ASSISTING IN PROMOTING SLEEP AND PREPARATION METHOD THEREOF | Aug 6, 2023 | Pending |
Array
(
[id] => 19216209
[patent_doc_number] => 20240180913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => THE THERAPEUTIC REGIMEN
[patent_app_type] => utility
[patent_app_number] => 18/219507
[patent_app_country] => US
[patent_app_date] => 2023-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18219507
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/219507 | Therapeutic regimen | Jul 6, 2023 | Issued |
Array
(
[id] => 18877359
[patent_doc_number] => 20240000728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => ESKETAMINE FOR THE TREATMENT OF DEPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/347393
[patent_app_country] => US
[patent_app_date] => 2023-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 115855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18347393
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/347393 | ESKETAMINE FOR THE TREATMENT OF DEPRESSION | Jul 4, 2023 | Abandoned |
Array
(
[id] => 19156022
[patent_doc_number] => 20240148729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => LOPINAVIR AND RITONAVIR FOR THE TREATMENT OF CERVIX DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/216937
[patent_app_country] => US
[patent_app_date] => 2023-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18216937
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/216937 | Lopinavir and ritonavir for the treatment of cervix disorders | Jun 29, 2023 | Issued |
Array
(
[id] => 18707472
[patent_doc_number] => 20230330046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => TARGETING OCULAR DISEASES WITH NOVEL APE1/REF-1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/341077
[patent_app_country] => US
[patent_app_date] => 2023-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18341077
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/341077 | TARGETING OCULAR DISEASES WITH NOVEL APE1/REF-1 INHIBITORS | Jun 25, 2023 | Abandoned |
Array
(
[id] => 19402071
[patent_doc_number] => 20240285582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE
[patent_app_type] => utility
[patent_app_number] => 18/340067
[patent_app_country] => US
[patent_app_date] => 2023-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18340067
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/340067 | Stable pharmaceutical compositions of edaravone | Jun 22, 2023 | Issued |
Array
(
[id] => 18707532
[patent_doc_number] => 20230330108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => MULTIPHASIC CONTRACEPTIVE REGIMEN FOR ORAL COMBINATION DRUG FORMULATION OF PROGESTIN AND ESTROGEN
[patent_app_type] => utility
[patent_app_number] => 18/336476
[patent_app_country] => US
[patent_app_date] => 2023-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6388
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18336476
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/336476 | Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen | Jun 15, 2023 | Issued |